![]() ![]() | Leeten, K., Jacques, N., Esquembre, L. A., Schneider, D. C., Straetener, J., Henriksen, C., MUSUMECI, L., Putters, F., Ferreira Melo, S., Sánchez-López, E., Giera, M., Penoy, N., Piel, G., Verlaine, O., Amoroso, A., Joris, B., Slavetinsky, C. J., Goffin, E., Pirotte, B., ... Oury, C. (2024). Ticagrelor alters the membrane of Staphylococcus aureus and enhances the activity of vancomycin and daptomycin without eliciting cross-resistance. MBio, 0132224. doi:10.1128/mbio.01322-24 ![]() |
![]() ![]() | Oury, C., Lancellotti, P., Leeten, K., & Jacques, N. (14 December 2023). N-alkyl-2-substituted ATP analogues for use as antibacterial agent. |
![]() ![]() | Lancellotti, P., Aqil, A., MUSUMECI, L., Jacques, N., Ditkowski, B., Debuisson, M., Thiry, M., Dupont, J., Gougnard, A., Sandersen, C., CHERAMY-BIEN, J.-P., Sakalihasan, N., Nchimi Longang, A., Detrembleur, C., Jérôme, C., & Oury, C. (2023). Bioactive surface coating for preventing mechanical heart valve thrombosis. Journal of Thrombosis and Haemostasis. doi:10.1016/j.jtha.2023.05.004 ![]() |
![]() ![]() | Xu, L., Henriksen, C., Mebus, V., Guérillot, R., Petersen, A., Jacques, N., Jiang, J.-H., Derks, R. J. E., Sánchez-López, E., Giera, M., Leeten, K., Stinear, T. P., Oury, C., Howden, B. P., Peleg, A. Y., & Frees, D. (2023). A Clinically Selected Staphylococcus aureus clpP Mutant Survives Daptomycin Treatment by Reducing Binding of the Antibiotic and Adapting a Rod-Shaped Morphology. Antimicrobial Agents and Chemotherapy, 0032823. doi:10.1128/aac.00328-23 ![]() |
![]() ![]() | Oury, C., Meyers, S., Jacques, N., Leeten, K., Jiang, Z., MUSUMECI, L., Lox, M., Debuisson, M., Goffin, E., Pirotte, B., Delvenne, P., Nchimi Longang, A., Hubert, C., Heptia, M., Hubert, P., Kuijpers, M. J. E., Vanassche, T., Martinod, K., Verhamme, P., & Lancellotti, P. (2023). Protective Effect of Ticagrelor Against Infective Endocarditis Induced by Virulent Staphylococcus aureus in Mice. JACC: Basic to Translational Science. doi:10.1016/j.jacbts.2023.02.003 ![]() |
![]() ![]() | LANCELLOTTI, P., Oury, C., Pirotte, B., MUSUMECI, L., Jacques, N., & Goffin, E. (23 September 2021). Preparation of pyrimidine derivatives for prevention and treatment of Gram-negative bacterial infection, contamination and fouling. |
![]() ![]() | Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x ![]() |
![]() ![]() | Oury, C., Pirotte, B., MUSUMECI, L., Jacques, N., Goffin, E., & LANCELLOTTI, P. (22 October 2020). New pyrimidine derivatives for prevention and treatment of gram negative bacterial infection, contamination and fouling. |
![]() ![]() | LANCELLOTTI, P., Jacques, N., & Oury, C. (17 April 2020). Tackling prosthetic heart valve-related deterioration: Liège translational cardiovascular research programme. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 15 (17), 1485-1487. doi:10.4244/EIJV15I17A272 ![]() |
![]() ![]() | Goffin, E., Jacques, N., Musumeci, L., Nchimi Longang, A., Oury, C., Lancellotti, P., & Pirotte, B. (2020). Synthesis of ticagrelor analogues belonging to 1,2,3-triazolo[4,5-d]pyrimidines and study of their antiplatelet and antibacterial activity. European Journal of Medicinal Chemistry, 208, 112767. doi:10.1016/j.ejmech.2020.112767 ![]() |
![]() ![]() | Oury, C., Musumeci, L., Jacques, N., & LANCELLOTTI, P. (2019). Activité antibiotique de l'antiplaquettaire ticagrelor : une nouvelle piste contre l'antibiorésistance. Vaisseaux, Coeur, Poumons, 24 (7), 8-13. ![]() |